Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignancies.
about
Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer RiskEstimation of Prognostic Marker Genes by Public Microarray Data in Patients with Ovarian Serous CystadenocarcinomaOvarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy.β-hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signalingSimultaneous dual targeting of Par-4 and G6PD: a promising new approach in cancer therapy? Quintessence of a literature review on survival requirements of tumor cells.
P2860
Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignancies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Exploiting the therapeutic pot ...... s of gynecologic malignancies.
@en
type
label
Exploiting the therapeutic pot ...... s of gynecologic malignancies.
@en
prefLabel
Exploiting the therapeutic pot ...... s of gynecologic malignancies.
@en
P2860
P1476
Exploiting the therapeutic pot ...... s of gynecologic malignancies.
@en
P2093
Krishnansu S Tewari
Ramez N Eskander
P2860
P304
P356
10.1586/17512433.2014.968554
P407
P577
2014-10-10T00:00:00Z